Activation of NMDA receptors is necessary for the recovery of cortical binocularity.
Classic experiments have indicated that monocular deprivation (MD) for a few days during a critical period of development results in a decrease in the strength of connections mediating responses to the deprived eye, leading to a dramatic breakdown of cortical neuron binocularity. Despite the substantial functional change in the visual cortex, recovery from the effects of MD can be obtained if binocular vision is promptly restored. While great efforts have been made to elucidate the mechanisms regulating loss of deprived eye function, the mechanisms that underlie the recovery of cortical binocularity are poorly understood. Here, we examined whether activation of the N-methyl-d-aspartate receptor (NMDAR) is required for the recovery of cortical binocularity by pharmacologically blocking the NMDAR using d,l-2-amino-5-phosphonopentanoic (APV). Ferrets (n = 10) were monocularly deprived for 6 days, and osmotic minipumps, filled with APV (5.6 mg/ml) or saline, were surgically implanted into the primary visual cortex. One day after surgery, the deprived eye was reopened, and the animals were allowed 24 h of binocular vision. Extracellular recordings showed that intracortical infusion of the NMDAR antagonist, APV, prevented recovery of cortical binocularity while preserving neuronal responsiveness. These findings provide an important new insight for a specific role of NMDARs in the recovery of cortical binocularity from the effects of MD.
Krahe
Thomas E
TE
Department of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298-0709, USA. tekrahe@vcu.edu
Medina
Alexandre E
AE
D000704:Analysis of Variance; D000818:Animals; D002404:Catheterization; D002452:Cell Count; D002491:Central Nervous System Agents / Q000008:administration & dosage / Q000494:pharmacology; D005289:Ferrets; D008839:Microelectrodes; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D010784:Photomicrography; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012683:Sensory Deprivation / Q000502:physiology*; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D015348:Vision, Binocular / Q000502:physiology*; D015349:Vision, Monocular / Q000502:physiology; D014793:Visual Cortex / Q000187:drug effects / Q000502:physiology*; D014796:Visual Perception / Q000187:drug effects / Q000502:physiology*
D002491:Central Nervous System Agents; D016194:Receptors, N-Methyl-D-Aspartate; C056639:2-amino-5-phosphopentanoic acid; D014633:Valine
Science. 1987 Oct 16;238(4825):355-8
2443978
Neuron. 2005 Oct 20;48(2):329-43
16242412
J Neurosci. 2003 Jul 2;23(13):5583-8
12843259
Neuron. 2004 Jan 22;41(2):185-92
14741100
Annu Rev Neurosci. 1990;13:129-54
2183671
Philos Trans R Soc Lond B Biol Sci. 2009 Feb 12;364(1515):357-67
18977732
Brain Res Dev Brain Res. 1989 Jun 1;47(2):281-8
2568191
J Neurosci. 2003 Nov 5;23(31):10002-12
14602814
Nat Neurosci. 1998 May;1(1):47-53
10195108
J Neurophysiol. 1998 Sep;80(3):1021-32
9744918
J Neurosci. 2002 Oct 15;22(20):9015-23
12388608
J Neurosci. 1986 Aug;6(8):2117-33
3746403
Neuroscience. 2006 Dec;143(3):815-26
17000056
Science. 1998 Nov 20;282(5393):1504-8
9822384
J Neurophysiol. 1999 Jan;81(1):204-15
9914281
Nat Rev Neurosci. 2007 May;8(5):379-91
17453018
J Neurosci. 1996 May 15;16(10):3274-86
8627365
J Neurosci. 1990 Mar;10(3):909-25
1969466
Invest Ophthalmol Vis Sci. 1994 Dec;35(13):4168-79
8002237
Trends Neurosci. 1993 Mar;16(3):116-22
7681235
Nature. 1992 Jun 25;357(6380):686-9
1377360
J Neurosci. 1999 Aug 15;19(16):6965-78
10436053
J Neurophysiol. 1989 Jul;62(1):185-97
2754471
Nature. 1993 Jan 7;361(6407):31-9
8421494
Nature. 2002 Mar 28;416(6879):430-3
11919632
Nature. 1987 Dec 17-23;330(6149):649-52
2446147
Neuroscience. 1998 Feb;82(3):687-700
9483528
Int J Dev Neurosci. 1990;8(4):425-35
1979202
Curr Biol. 2003 Sep 30;13(19):1704-8
14521836
Proc Natl Acad Sci U S A. 1989 Jul;86(13):5183-7
2567996
J Pharmacol Exp Ther. 1981 Jun;217(3):841-50
7230011
J Neurophysiol. 2006 Mar;95(3):1718-26
16354732
J Neurosci. 1999 Aug 15;19(16):7089-99
10436063
Proc Natl Acad Sci U S A. 1973 Apr;70(4):997-1001
4352227
J Neurosci. 2003 Nov 12;23(32):10283-91
14614087
J Neurophysiol. 1999 May;81(5):2587-91
10322092
Curr Opin Ophthalmol. 1992 Dec;3(6):735-40
10147973
Cell. 1993 Jan;72 Suppl:65-75
8094038
J Neurophysiol. 2004 Oct;92(4):2113-21
15102897
Neuron. 2002 Apr 25;34(3):425-36
11988173
J Comp Neurol. 1988 Dec 8;278(2):157-80
3068264
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5377-82
19276107
J Physiol. 1978 Jan;274:511-37
625006
Neuropharmacology. 2007 Jan;52(1):200-14
16895734
Nat Neurosci. 2008 Apr;11(4):497-504
18311133
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11662-7
11573003
J Neurosci. 1997 Apr 1;17(7):2469-76
9065507
Neuroscience. 1986 Aug;18(4):1035-46
2876398